Sugentech

Sugentech Inc. (KOSDAQ: 253840) is a South Korean in-vitro diagnostics (IVD) company established in 2011 as a spin-off from INNOPOLIS Research Institute of the Ministry of Science and ICT. The company develops and commercializes a full spectrum of diagnostic products including self-testing kits (pregnancy, ovulation, menopause hormones), Point-of-Care Testing (POCT) devices, and fully automated immunoblot systems, leveraging BT-IT-NT convergence technology. Sugentech's products have been deployed in over 120 countries, including COVID-19 antigen and antibody rapid tests that received FDA EUA and CE approval, and the company continues to advance next-generation diagnostics for allergies, active TB, microalbumin testing, and dementia.